Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$18.71 0.04 (0.21%)
2/9/2010 4:00 PM

Immucor, Inc. (BLUD)

CAPS Rating:
*****

The Company develops, manufactures and sells a complete line of reagents and automated systems used by hospitals, clinical laboratories and blood banks in tests performed to detect and identify certain properties of human blood.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BLUD

Add Stock to Watchlist

What the Community Thinks

Total Members

570 Outperforms
20 Underperforms
 

All-Stars

173 Outperforms
2 Underperforms
 

Wall Street

4 Outperforms
0 Underperforms
 

Members bullish on BLUD are also bullish on:

Members bearish on BLUD are also bearish on:

Ticker Tags

Healthcare (711), Growth (1902), Healthcare Equipment and Supplies (176), Small Cap (1645), Defensive (1457)
Suggest a tag

Immucor, Inc. At A Glance

Current Price: $18.71
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $18.67
Daily Range: $18.59 - $19.00
52-Week Range: $11.24 - $29.05
Volume: 667,414
Market Cap: $1.31B
P/E Ratio: 16.52
Compare Our Special Broker Offers!

Stock Trends

BLUD VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for BLUD

More Headlines...

Top Bull Pitch

Recs

8

Immucor, Inc. (BLUD)

Avatar tenmiles (99.99) Submitted: 6/15/09 11:12 AM

Siding with a host of better informed longs on Immucor at $15.59. Large short position in company recently drove it down from $30 range, where an activist hedge fund has recently taken a 6% stake. Financial flexible company - debt free with healthy ROE and reasonable forward P/E. Longer term pla...More

Replies: 4 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 88 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (BLUD)

Avatar sobaka1197 (< 20) Submitted: 1/13/10 3:33 PM : Outperform Start Price: $20.41 BLUD Score: -1.70

BLUD (and the rest in the IBB universe). Biomicrotechnology is where it's going be. Get in now.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar Neryblop (< 20) Submitted: 1/12/10 1:19 AM : Outperform Start Price: $20.26 BLUD Score: -1.73

Current P/E Ratio 18.0 20.5 28.7


P/E Ratio 5-Year High 70.2 45.2 32.3


P/E Ratio 5-Year Low 12.5 13.0 2.8


Price/Sales Ratio 4.43 19.81 2.28


Price/Book Value 3.35 5.02 3.50


Price/Cash Flow Ratio 14.90 16.10 14.10


Look at the average P/E ratio. ITs udnervalued in comparison to industry. Many other positive stats in regards to P/E.





It goes company industry and S and P for numbers for top and bottom.





Return On Equity 21.1 5.1 14.2


Return On Assets 18.2 7.0 5.5


Return On Capital 20.3 -49.2 7.7


Return On Equity (5-Year Avg.) 26.4 -28.4 19.0


Return On Assets (5-Year Avg.) 21.2 4.8 7.9


Return On Capital (5-Year Avg.) 24.6 6.4 10.6





the ROI is outstanding, so its a no brainer.





I looked at the financial statements. CUrrents ASsets is way more than current liabilities so do not worry about it filing for bankruptcy any time soon.





Some discrepancies however is it has very few competitors in the business of blood, so clearly more competitors will arrive in the future. I am not entirely sure, but the company is accused of price gouging. its likely cuz its a monopoly.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar hrc777 (54.36) Submitted: 12/23/09 8:46 AM : Outperform Start Price: $19.83 BLUD Score: -2.32

slow steady growth, no debt. sell close below 50 ema (18.88)

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar ps1160 (98.45) Submitted: 12/16/09 11:29 AM : Outperform Start Price: $19.80 BLUD Score: -1.19

Good use of capital, no LT debt (ROIC 27%, Operating Margin 25%). Broad customer base with high percentage of recurring orders. My only concern is the recent FDA investigations into the quality of their reagents. However, management has been transparent about it and has a plan (and $$) in place to mitigate this risk in the future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BLUD)

Avatar jasenj1 (91.17) Submitted: 12/09/09 1:12 PM : Outperform Start Price: $19.24 BLUD Score: -0.74

Trade of the Week rec. It's an older rec from Nov, but it seems to be doing well. Hope there is still upside.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 88 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRWBaird 87.00 12/15/08 Outperform NS $23.03-18.76%+23.57%-42.33
TrackSusquehanna 74.67 03/19/08 Outperform NS $21.98-14.88%-16.70%+1.82
TrackRonBaron 59.71 09/30/07 Outperform NS $35.75-47.66%-26.38%-21.29 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer < 20 05/23/06 Outperform 3W $17.29+8.21%-9.34%+17.55

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 921ms